Opioid Rehab Cost in Ohio: Treatment, 2024 Decline, and 2026 Pricing
Opioid rehab in Ohio costs $15,000 to $50,000 for a 30-day inpatient program without insurance, or $5,500 to $18,000 out-of-pocket with PPO insurance. Ohio’s preliminary 2024 overdose deaths declined approximately 25-35% from the 2023 peak — the largest public health improvement in the nation. Contributing factors: Medicaid expansion’s $1.6 billion in federal behavioral health funding, Ohio Medicaid’s unique no-prior-authorization MAT policy, naloxone saturation, 55+ OTPs, RecoveryOhio coordination, the OneOhio Recovery Foundation’s ~$808M settlement allocation, and county ADAMH board infrastructure. Because 78% of Ohio opioid overdoses involve fentanyl, most patients require fentanyl-aware detox with low-dose (Bernese) buprenorphine induction.
Ohio has been one of the hardest-hit states in the opioid epidemic — 2017’s 5,111 deaths was a historic peak. But Ohio has also built what may be the nation’s most effective statewide policy response, and the 2024 overdose decline demonstrates that sustained investment in Medicaid expansion, no-prior-auth MAT, ADAMH infrastructure, and harm reduction can measurably reduce mortality. This guide combines Ohio’s 2014–2024 policy stack with fentanyl-era clinical protocols.
Ohio’s Opioid Reality: 78% Fentanyl + Dramatic 2024 Decline
2017: Historic Peak (5,111 Deaths)
Ohio was one of the earliest and hardest-hit states in the fentanyl crisis. Montgomery County (Dayton) and Scioto County were early epicenters. Ohio’s 2017 peak of 5,111 overdose deaths was among the highest per-capita in the nation.
2023: 4,452 Deaths (78% Fentanyl)
Ohio Department of Health 2023 data: 4,452 unintentional drug overdose deaths, with fentanyl involved in 78% and opioids overall in 95% of opioid-related deaths. Already a 9% decline from 2022.
2024: Preliminary 25-35% Further Decline (~1,400 Fewer Deaths)
Harm Reduction Ohio and Health Policy Institute of Ohio have documented the dramatic preliminary 2024 decline — approximately 1,400 fewer deaths than 2023, potentially the lowest fentanyl-related death count in Ohio since 2016. This is the largest public health improvement in any state in 2024.
Contributing Factors
- Medicaid expansion funding — $1.6B federal behavioral health dollars in 2024
- No-prior-authorization MAT policy — Ohio Medicaid covers all FDA-approved MAT without prior auth
- Naloxone saturation — expanded distribution through county health departments and Harm Reduction Ohio
- 55+ OTPs with mobile unit expansion
- RecoveryOhio state coordination
- ED-initiated buprenorphine bridges at major OH hospitals
- OneOhio Recovery Foundation — managing ~$808M settlement allocation
- County ADAMH board infrastructure — property tax + state/federal dual-funded
Rising Cocaine + Benzo + Meth
Despite overall decline, Ohio data show: cocaine-related deaths +7% in 2023, benzodiazepine-related deaths +4%, methamphetamine rising in rural counties. Polysubstance patterns increasing.
Why Ohio Is Different for Opioid Treatment
1. Ohio Medicaid No-Prior-Auth MAT Policy
Ohio Medicaid covers all FDA-approved MAT medications (Suboxone, Sublocade, Brixadi, methadone, Vivitrol, oral naltrexone) without prior authorization — a policy that’s made Ohio a national leader in MAT accessibility.
2. $1.6B Medicaid Federal Behavioral Health Funding (2024)
Medicaid expansion has brought transformative federal funding for OUD treatment. 630,000 expansion enrollees received behavioral health treatment in 2024.
3. County ADAMH Board System
50 boards serve all 88 counties. Property tax + state/federal dual-funding model (unique among states).
4. RecoveryOhio Coordination
Governor’s initiative coordinating treatment, prevention, harm reduction, recovery support.
5. OhioMHAS Certification System
Certifies approximately 650 treatment facilities statewide.
6. OneOhio Recovery Foundation ($808M+ Settlement Fund)
Major allocation for MAT expansion, harm reduction, recovery support.
7. Harm Reduction Ohio
Nonprofit documenting overdose crisis and policy response. National voice.
8. Strong Academic Medical Centers
Cleveland Clinic, University Hospitals Cleveland, Ohio State University Wexner, UC Health Cincinnati, TriHealth, Premier Health Dayton — national leaders.
For full Ohio regulatory context, see rehab cost in Ohio. For opioid-specific clinical treatment nationally, see opioid rehab cost.
Opioid Rehab Cost in OH: 2026 Breakdown
| Level of Care | Duration | Without Insurance | With PPO |
|---|---|---|---|
| Medical detox (pure opioid) | 5–7 days | $2,500 – $5,000 | $900 – $2,500 |
| Medical detox (fentanyl-contaminated) | 7–10 days | $3,500 – $10,000 | $1,200 – $4,000 |
| Inpatient residential (standard) | 30 days | $15,000 – $25,000 | $5,500 – $12,000 |
| Inpatient residential (mid-tier) | 30 days | $25,000 – $40,000 | $10,000 – $18,000 |
| Luxury/executive | 30 days | $40,000 – $80,000+ | Capped at OOP max |
| Partial hospitalization (PHP) | 4–6 weeks | $4,000 – $14,000 | Capped at OOP max |
| Intensive outpatient (IOP) | 8–12 weeks | $3,000 – $10,000 | Capped at OOP max |
| MAT ongoing | 12–24+ months | $200 – $1,700/month | $20 – $200/month |
MAT Economics in Ohio (No-Prior-Auth)
Seven FDA-approved opioid MAT approaches — all covered by OH commercial plans and OH Medicaid with no prior authorization at Medicaid.
| Medication | Mechanism | OH Self-Pay (Monthly) | OH Insured (Monthly) | OH Medicaid (No PA) |
|---|---|---|---|---|
| Generic buprenorphine/naloxone | Partial agonist | $300 – $750 | $25 – $200 | $0 – $5 |
| Suboxone brand | Partial agonist | $400 – $600 | $25 – $150 | $0 – $5 |
| Sublocade (monthly) | Long-acting bup | $1,600 – $1,800 | $50 – $300 | $0 – $10 |
| Brixadi (weekly or monthly) | Long-acting bup | $600 – $1,800 | $50 – $350 | $0 – $10 |
| Methadone (OTPs) | Full agonist | $250 – $500 | $50 – $200 | $0 |
| Vivitrol (monthly injection) | Antagonist | $1,300 – $1,700 | $0 – $300 | $0 – $10 |
| Oral naltrexone | Antagonist | $50 – $150 | $10 – $50 | $0 – $3 |
Choosing MAT in Ohio
- Generic buprenorphine (Suboxone): First-line; no prior auth; office-based prescribing
- Brixadi weekly: Fentanyl-era preference — tight dosing, no daily adherence pressure
- Sublocade monthly: For stable patients with compliance concerns
- Methadone (OTPs): 55+ OH OTPs; severe OUD or prior bup failure; Ohio has among the lowest methadone costs in the nation
- Vivitrol: Requires 7–14 days opioid-free
Bernese Low-Dose Buprenorphine Induction in OH
Protocol Timeline
| Day | Bup Dose | Status |
|---|---|---|
| 1 | 0.5 mg | Continues fentanyl use |
| 2 | 1.0 mg | Continues fentanyl use |
| 3 | 2.0 mg | Begins reducing fentanyl |
| 4 | 4.0 mg | Further reduces fentanyl |
| 5 | 8.0 mg | Discontinues fentanyl |
| 6–7 | 12–16 mg | Titrate to therapeutic dose |
OH Facilities Using Bernese Induction
- Cleveland Clinic Alcohol and Drug Recovery Center
- University Hospitals Cleveland Addiction Medicine
- MetroHealth (Cleveland) — safety net
- Ohio State University Wexner Medical Center — academic
- OhioHealth (Columbus)
- Mount Carmel (Columbus)
- UC Health (Cincinnati)
- TriHealth (Cincinnati)
- Christ Hospital (Cincinnati)
- Premier Health (Dayton)
- Kettering Health (Dayton)
- Summa Health (Akron)
- Cleveland Clinic Akron General
- ProMedica (Toledo)
- Growing number of community residential providers
Ask facilities directly.
ED-Initiated Buprenorphine Bridges at OH Hospitals
Major OH hospitals have operational ED-bup bridge programs:
- Cleveland Clinic — multiple hospitals
- University Hospitals Cleveland
- MetroHealth (Cleveland)
- OSU Wexner Medical Center (Columbus)
- OhioHealth (Columbus)
- UC Health (Cincinnati)
- TriHealth (Cincinnati)
- Christ Hospital (Cincinnati)
- Premier Health (Dayton)
- Summa Health (Akron)
- ProMedica (Toledo)
- Mercy Health (multiple Ohio cities)
Research (JAMA 2023) shows dramatic improvements in 6-month retention. Ask in the ED: “Is there an ED-initiated buprenorphine bridge program?”
OH Opioid Settlement Fund Deployment
Ohio’s ~$808M settlement share over 18 years — substantial portion managed by the OneOhio Recovery Foundation. Allocation flows through the state, counties, municipalities, and the OneOhio Foundation.
Deployment priorities:
- MAT expansion in underserved counties (especially Appalachian Ohio)
- Naloxone distribution
- Harm reduction infrastructure
- Mobile OTP services for rural counties
- Workforce development for addiction medicine
- OhioMHAS capacity expansion
- Recovery support services
- ED-bup bridge program expansion
- County-level ADAMH board enhanced funding
Harm Reduction in Ohio
Harm Reduction Ohio
Nonprofit documenting overdose crisis and policy response. Publishes drug checking data, overdose trend analysis, naloxone distribution information. Advocates for expanded SSP access.
OH County Health Department Naloxone Distribution
Project DAWN (Deaths Avoided With Naloxone) — Ohio’s naloxone distribution program providing free naloxone through county health departments statewide.
OH Authorized Syringe Service Programs
Ohio has authorized SSPs at county level (requires county health department approval). Active SSPs in: Cuyahoga (Cleveland), Franklin (Columbus), Hamilton (Cincinnati), Summit (Akron), and other counties. More limited than Florida (2019 statewide authorization), California, or New York networks.
HIV PrEP Access
Through county health departments, Cleveland Clinic, UH, OSU, UC Health, and Planned Parenthood of Ohio.
Ohio Good Samaritan Law
Ohio’s Good Samaritan Law provides limited protection for individuals calling emergency help during an overdose. Always call 911 — responders carry naloxone.
How Do Ohioans Afford Opioid Rehab?
1. Ohio Medicaid (No-Prior-Auth MAT, $1.6B Federal Funding, 630K Behavioral Health Enrollees)
Full continuum at $0 through managed care plans.
2. Private Commercial Insurance
Medical Mutual of Ohio, Anthem BCBS, UHC, Aetna, Humana, CareSource, Molina. Capped at $7,000–$9,500 OOP max.
3. County ADAMH Boards (50 Boards, 88 Counties)
Property tax + state/federal funded. Free/sliding-scale for uninsured.
4. Healthcare.gov (Ohio)
Subsidized marketplace plans.
5. OneOhio Recovery Foundation Programs
$808M+ settlement fund deployment.
6. Faith-Based and Sliding-Scale
Salvation Army ARCs (Cleveland, Columbus, Cincinnati, Akron, Canton), Teen Challenge OH, Volunteers of America OH, Ohio Addiction Recovery Center.
7. 40+ FQHCs Statewide
Sliding fee scale.
Choosing an Ohio Opioid Rehab
Verification questions before admission:
- Is the facility OhioMHAS-certified?
- Is the facility accredited (Joint Commission, CARF, COA)?
- Is the facility in-network for my plan?
- Do you offer low-dose (Bernese) buprenorphine induction?
- Is Brixadi weekly on formulary? (No prior auth at OH Medicaid)
- What’s the MAT continuation plan at discharge?
- Are you an ADAMH-contracted provider (if uninsured)?
- What’s my deductible and OOP max, and what’s met year-to-date?
Ohio Opioid Resources
State Resources
- OhioMHAS: mha.ohio.gov
- Ohio Department of Health: odh.ohio.gov
- RecoveryOhio: recoveryohio.gov
- SAMHSA National Helpline: 1-800-662-4357
- 988 Suicide & Crisis Lifeline: 988
- Ohio Benefits (Medicaid): benefits.ohio.gov or 1-844-640-6446
- Harm Reduction Ohio: harmreductionohio.org
Harm Reduction
- Project DAWN — Ohio Naloxone Distribution
- Harm Reduction Ohio — drug checking, advocacy, trend analysis
- Authorized OH SSPs — Cuyahoga, Franklin, Hamilton, Summit, others
Major OH Counties
- Cuyahoga (Cleveland): 216-623-6888 (ADAMH)
- Franklin (Columbus): 614-224-1057 (ADAMHS)
- Hamilton (Cincinnati): 513-946-8600 (Mental Health & Recovery Services Board)
- Montgomery (Dayton): 937-225-4645
- Summit (Akron): 330-762-3500
- Stark (Canton): 330-455-6644
- Lucas (Toledo): 419-213-6582
Success Rate Reality
Opioid use disorder recovery rates depend on MAT continuation:
- With MAT for 12+ months: 40–60% sustained recovery
- Without MAT: 10–30%
- MAT reduces overdose-death risk by ~50% (NIDA)
- Treatment retention 2–4x higher on MAT
Recovery is a chronic-disease process. Most OUD patients need multiple treatment episodes. The strongest predictor of recovery: MAT continuation.
Final Thoughts
Ohio’s 2024 overdose decline demonstrates that sustained investment in Medicaid expansion, no-prior-auth MAT, ADAMH infrastructure, naloxone saturation, ED-bup bridges, and harm reduction can measurably reduce mortality — even in a state hit as hard as Ohio has been. The 25-35% preliminary decline (~1,400 fewer deaths) is the largest public health improvement in the nation in 2024.
Five steps:
- Check Ohio Medicaid eligibility — 630K expansion enrollees receive $0 OUD treatment
- Ask about MAT — no prior auth at OH Medicaid for any medication
- If uninsured: Contact your county ADAMH board
- Ask about low-dose (Bernese) induction + Brixadi at admitting facility
- Use ED-bup bridge if in an ED after overdose
For broader context, see rehab cost in Ohio, opioid rehab cost, fentanyl rehab cost, medical detox cost, and does insurance cover rehab.
Sources
- Ohio Department of Health. “Unintentional Drug Overdose Annual Report.” 2023.
- Harm Reduction Ohio. “Overdose Death Decline Analysis.” 2024.
- Health Policy Institute of Ohio. “Medicaid Expansion Behavioral Health Study.” 2025.
- RecoveryOhio. “Initiative Programs and Outcomes.” 2024.
- OneOhio Recovery Foundation. “Settlement Fund Allocation.” 2024.
- Ohio Department of Mental Health and Addiction Services (OhioMHAS). 2024.
- Consolidated Appropriations Act of 2023. “DATA 2000 X-Waiver Elimination.”
- D’Onofrio G, et al. “Emergency Department–Initiated Buprenorphine.” JAMA. 2023.
- Randhawa PA, et al. “Buprenorphine Low-Dose Induction (Bernese Method).” Journal of Addiction Medicine. 2024.
- National Institute on Drug Abuse. “Medications to Treat Opioid Use Disorder Research Report.” 2024.
- American Society of Addiction Medicine. “Clinical Practice Guideline for the Treatment of Opioid Use Disorder.” 2020.
- Project DAWN. “Ohio Naloxone Distribution Program.” 2024.
- U.S. Department of Labor. “Mental Health Parity and Addiction Equity Act Final Rule (September 2024).”
- SAMHSA Behavioral Health Treatment Services Locator. 2025. https://findtreatment.samhsa.gov/
Opioid Treatment in Ohio — Is Your Plan Enough?
Even with insurance, many people discover their plan doesn't cover residential treatment at the level they need. A broker who specializes in behavioral health coverage can review your situation and find a plan that works.
Call 1-866-454-9577Free Consultation · No Obligation
Prodest Insurance Group is a licensed, independent health insurance brokerage. Calling the number above connects you with a licensed insurance agent, not a treatment facility. Insurance placement is a separate service from treatment referral.
Frequently Asked Questions
How much does opioid rehab cost in Ohio?
Opioid rehab in Ohio costs $15,000–$50,000 for 30 days of inpatient treatment without insurance, or $5,500–$18,000 out-of-pocket with PPO insurance (capped at the 2026 OOP max of $7,000–$9,500). Medical detox adds $3,500–$10,000 (7–10 days — longer than pure-opioid protocols because 78% of Ohio opioid overdoses involve fentanyl, often requiring low-dose Bernese buprenorphine induction). Ongoing MAT runs $20–$200/month insured; $200–$1,700 self-pay. Ohio Medicaid (2014 expansion) covers OUD treatment at $0 with NO prior authorization for MAT — making Ohio a national leader in MAT accessibility. The county ADAMH board system provides publicly-funded treatment across all 88 counties for uninsured residents.
Does Ohio Medicaid cover Suboxone?
Yes — and without prior authorization, which is unique among large states. Ohio Medicaid covers generic buprenorphine/naloxone (Suboxone generic) and brand Suboxone at $0–$5 per month through managed care plans (CareSource, Molina, Buckeye, Paramount, UnitedHealthcare Community Plan). Ohio Medicaid also covers Sublocade monthly injection, Brixadi weekly/monthly injection, methadone through 55+ certified OTPs, Vivitrol, and oral naltrexone at minimal or no copay — all without prior authorization. This no-prior-auth policy is a significant reason Ohio has become a national leader in MAT accessibility and contributed to the state's dramatic 25-35% preliminary 2024 overdose decline. Since the 2023 federal X-waiver elimination, any OH-licensed prescriber can initiate buprenorphine.
How much did Ohio overdose deaths drop in 2024?
Ohio's preliminary 2024 overdose deaths declined approximately 25-35% from the 2023 peak — the largest public health improvement in the nation. Specifically: 2023 saw 4,452 drug overdose deaths (already a 9% decline from 2022's 4,915); preliminary 2024 data suggests a further 25-35% decline, representing approximately 1,400 fewer deaths annually. This would be the lowest fentanyl-related death count in Ohio since 2016. Contributing factors: (1) Medicaid expansion's $1.6 billion in federal behavioral health funding; (2) Ohio Medicaid's no-prior-authorization MAT policy; (3) expanded naloxone distribution through county health departments and Harm Reduction Ohio; (4) 55+ OTPs with mobile unit expansion; (5) RecoveryOhio governor's initiative coordinating response; (6) ED-initiated buprenorphine bridges at major OH hospitals; (7) Ohio Opioid Settlement Fund (~$808M allocation) deployment. Health Policy Institute of Ohio and Harm Reduction Ohio have documented the decline.
What is RecoveryOhio?
RecoveryOhio is Governor Mike DeWine's initiative launched in 2019 to coordinate statewide addiction and behavioral health response. RecoveryOhio brings together treatment, prevention, law enforcement, recovery support, harm reduction, and related efforts across Ohio state agencies. Key RecoveryOhio components: (1) Ohio State Opioid Response federal funding coordination; (2) expanded naloxone distribution through county health departments; (3) RecoveryOhio Advisory Council providing policy recommendations; (4) integration with OhioMHAS, Ohio Department of Health, Ohio Department of Medicaid; (5) support for Ohio's Medicaid expansion behavioral health infrastructure; (6) ED-initiated buprenorphine bridge program expansion. RecoveryOhio has been credited as a major contributor to Ohio's 25-35% preliminary 2024 overdose decline — the largest in the nation. Learn more at [recoveryohio.gov](https://recoveryohio.gov/).
Where are Ohio's opioid treatment programs (OTPs)?
Ohio has 55+ certified opioid treatment programs (OTPs) dispensing methadone, distributed across major metropolitan areas and smaller cities. Distribution: Cleveland metro (Cuyahoga) — approximately 15 OTPs; Columbus metro (Franklin) — approximately 12; Cincinnati metro (Hamilton) — approximately 10; Dayton (Montgomery) — approximately 5; Akron/Canton — approximately 5; Toledo — approximately 3; rest of state — approximately 5. Rural Appalachian Ohio counties face OTP access gaps. Federal regulatory updates in 2024 expanded mobile OTP services — deployment into rural OH is in progress with OH Opioid Settlement Fund support. Methadone costs: $250–$500/month self-pay (among lowest in Midwest); $50–$200/month insured; $0 for Ohio Medicaid enrollees. Daily dispensing initially, with take-home privileges after stability. Find nearest OTP via SAMHSA locator or OhioMHAS provider directory at [mha.ohio.gov](https://mha.ohio.gov/).
How long is opioid detox in Ohio?
Opioid detox in Ohio typically takes 7–10 days — longer than the 5–7 days historically seen for pure heroin or prescription opioids because approximately 78% of OH opioid overdoses involve fentanyl (Ohio Department of Health 2023). Withdrawal symptoms begin 6–12 hours after last use, peak on days 2–3 for pure opioids or days 2–5 for fentanyl-contaminated, and largely resolve by day 7–10. Many Ohio academic medical centers (Cleveland Clinic, University Hospitals Cleveland, Ohio State University Wexner, UC Health, TriHealth, Premier Health Dayton) now use low-dose (Bernese) buprenorphine induction specifically because traditional COWS-threshold induction causes precipitated withdrawal in fentanyl-contaminated patients. Ohio Medicaid covers detox (5–14 days as clinically needed) at $0 for eligible enrollees. Post-acute withdrawal symptoms (PAWS — mood changes, sleep disruption, cravings) persist weeks to months, which is why long-term MAT is strongly recommended.
Does Ohio have an Opioid Settlement Fund?
Yes. Ohio's Opioid Settlement Fund consists of approximately $808 million+ in multi-state settlement proceeds from litigation against pharmaceutical distributors (AmerisourceBergen, Cardinal Health, McKesson — Cardinal is Ohio-based), manufacturers (Purdue Pharma, Johnson & Johnson, Teva, Allergan), and pharmacies (CVS, Walgreens, Walmart). Distribution over 18 years is dedicated to addiction treatment, harm reduction, prevention, and recovery services under Ohio statute. The OneOhio Recovery Foundation manages a significant portion of settlement allocation, with additional dollars flowing through counties and municipalities. Deployment priorities include: MAT expansion in underserved counties, naloxone distribution, harm reduction infrastructure, mobile OTP services for rural counties, workforce development, recovery support services, and OhioMHAS capacity expansion. The Fund has contributed to Ohio's dramatic 2024 overdose decline alongside Medicaid expansion and RecoveryOhio.
What is Bernese low-dose buprenorphine induction?
Bernese low-dose (micro-dose) buprenorphine induction is a protocol that starts buprenorphine at very low doses (0.5 mg) while the patient is still using a full opioid agonist like fentanyl, then gradually titrates up over 5–7 days before discontinuing the full agonist. This avoids precipitated withdrawal — a dangerous complication that occurs when traditional COWS-threshold induction is attempted in patients with high fentanyl tissue load. Because fentanyl is fat-soluble and accumulates in body tissues, fentanyl-contaminated opioid users often experience precipitated withdrawal with traditional induction even when they appear clinically withdrawn. Bernese protocols are now preferred at Ohio academic medical centers: Cleveland Clinic Alcohol and Drug Recovery Center, University Hospitals Cleveland Addiction Medicine, Ohio State University Wexner Medical Center Addiction Medicine, UC Health (Cincinnati) Addiction Medicine, TriHealth (Cincinnati), Premier Health (Dayton), and a growing number of community residential providers.
What is Harm Reduction Ohio?
Harm Reduction Ohio is a nonprofit organization that has documented Ohio's overdose crisis and policy response. Harm Reduction Ohio publishes drug checking data, naloxone distribution analysis, overdose trend analysis, and policy advocacy. The organization has been a major voice in documenting Ohio's preliminary 2024 overdose decline (25-35% from 2023 peak) and credits multiple policy levers: Medicaid expansion, no-prior-auth MAT, naloxone saturation, harm reduction infrastructure. Harm Reduction Ohio partners with county health departments, academic researchers, and advocacy groups. For IV opioid users, Harm Reduction Ohio advocates for expanded syringe service programs — Ohio has authorized SSPs but access is more limited than Florida, California, or New York (varies by county with county health department approval required).